معرفی
Shai Mulinari is an Associate Professor and Senior Lecturer in Sociology at Lund University. His research focuses on the interplay between market forces, regulatory frameworks, and medical science in shaping pharmaceutical development and use. Key areas include pharmaceutical industry transparency, drug regulation, and the sociological dimensions of medical research. He leads projects funded by the Swedish Research Council and WASP-HS, exploring topics such as AI in biomedicine and the use of racial/ethnic categories in clinical research. Mulinari has published extensively in journals like BMJ, Social Science & Medicine, and Health Policy, addressing issues ranging from drug approval processes to industry self-regulation failures. His work emphasizes critical analysis of healthcare policies and the ethical implications of commercial influence in medicine.
- Education: PhD in Sociology from Lund University (2008).
- Key Projects: Investigates pharmaceutical transparency, regulatory decision-making, and AI's impact on biomedicine.
Research Interests: His interdisciplinary approach spans pharmaceutical industry critique, regulatory sociology, and the historical development of biomedical theories. Current projects analyze racial categorization in clinical trials and the consequences of AI-driven diagnostics.
Publications: Over 99 publications since 2006, with recent work focusing on transparency gaps in drug company payments and comparative analyses of drug approvals across regions.
Grants & Funding: Swedish Research Council, WASP-HS, and international collaborations on pharmaceutical regulation and AI in healthcare.
